RA
Radiopharm Theranostics Limited (RADX)
NASDAQ·Healthcare·Biotechnology
$4.36
-6.24%
Mkt Cap $6.36M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$14.00
Range $13.00 – $15.00
Implied Upside
+221.1%
Consensus $14.00 vs current $4.36